Comparison of General Anesthesia and Continuous Intravenous Sedation for Electrochemotherapy of Head and Neck Skin Lesions

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Dec 5

PMID 36465339

Authors

Janez Benedik

Barbara Ogorevc

Simona Kranjc Brezar

Maja Cemazar

Gregor Sersa

Ales Groselj

Affiliations

Soon will be listed here.

Abstract

Background: Electrochemotherapy of cutaneous tumor nodules requires local or general anesthesia. For multiple and larger nodules, general anesthesia is recommended by standard operating procedures. The choice of general anesthesia is at the discretion of the treating center. Continuous intravenous sedation is also an option. Our study aimed to elucidate the tolerability, safety and possible advantages of continuous intravenous sedation in comparison to general anesthesia in patients undergoing electrochemotherapy.

Patients And Methods: In the prospective study, 27 patients undergoing electrochemotherapy were either under general anesthesia or under continuous intravenous sedation. Evaluated were different endpoints, such as feasibility and safety, duration of anesthesia and compliance with the patients.

Results: Ten patients were treated under general anesthesia, and 17 patients were under continuous intravenous sedation. The comparison of the approaches indicated that continuous intravenous sedation required a lower overall dosage of propofol, a shorter duration of anesthesia, a shorter time to reach an Aldrete score >8, and greater satisfaction of the patients with the procedure compared to general anesthesia.

Conclusion: The results indicate the feasibility and safety of continuous intravenous sedation for patients undergoing electrochemotherapy of cutaneous tumor nodules. This proved the preferred choice of anesthesia due to its shorter duration and better compliance with the patients compared to general anesthesia.

Citing Articles

Reversible electroporation for cancer therapy.

Shiwani T, Singh Dhesi S, Dhesi S, Wah T Br J Radiol. 2024; 98(1167):313-320.

PMID: 39579146 PMC: 11840168. DOI: 10.1093/bjr/tqae231.

The role of electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinoma: long-term results.

Vass A, Polgar N, Sandor S, Agoston D, Rozsa P, Csanyi I Int J Dermatol. 2024; 64(1):111-118.

PMID: 38924059 PMC: 11685057. DOI: 10.1111/ijd.17346.

Treatment of vulvar cancer recurrence with electrochemotherapy: a case-control study.

Vivod G, Omerzel M, Kovacevic N, Gasljevic G, Cilensek I, Sersa G Acta Oncol. 2024; 63:351-357.

PMID: 38770722 PMC: 11332505. DOI: 10.2340/1651-226X.2024.33241.

Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report.

Muir T, Bertino G, Groselj A, Ratnam L, Kis E, Odili J Radiol Oncol. 2023; 57(2):141-149.

PMID: 37341196 PMC: 10286891. DOI: 10.2478/raon-2023-0029.

References

Fahy B, Chau D . The Technology of Processed Electroencephalogram Monitoring Devices for Assessment of Depth of Anesthesia. Anesth Analg. 2017; 126(1):111-117. DOI: 10.1213/ANE.0000000000002331. View

Trotovsek B, Djokic M, Cemazar M, Sersa G . New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies. World J Gastroenterol. 2022; 27(48):8216-8226. PMC: 8717013. DOI: 10.3748/wjg.v27.i48.8216. View

Giordano D, Raso M, Pernice C, Agnoletti V, Barbieri V . Topical local anesthesia: focus on lidocaine-tetracaine combination. Local Reg Anesth. 2015; 8:95-100. PMC: 4669927. DOI: 10.2147/LRA.S41836. View

Gehl J, Sersa G, Matthiessen L, Muir T, Soden D, Occhini A . Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol. 2018; 57(7):874-882. DOI: 10.1080/0284186X.2018.1454602. View

Aubrun F . Management of postoperative analgesia in elderly patients. Reg Anesth Pain Med. 2005; 30(4):363-79. DOI: 10.1016/j.rapm.2005.02.006. View

Mayhew D, Mendonca V, Murthy B . A review of ASA physical status - historical perspectives and modern developments. Anaesthesia. 2019; 74(3):373-379. DOI: 10.1111/anae.14569. View

Waldinger R, Weinberg G, Gitman M . Local Anesthetic Toxicity in the Geriatric Population. Drugs Aging. 2019; 37(1):1-9. DOI: 10.1007/s40266-019-00718-0. View

Campana L, Marconato R, Valpione S, Galuppo S, Alaibac M, Rossi C . Basal cell carcinoma: 10-year experience with electrochemotherapy. J Transl Med. 2017; 15(1):122. PMC: 5452531. DOI: 10.1186/s12967-017-1225-5. View

Karcioglu O, Topacoglu H, Dikme O, Dikme O . A systematic review of the pain scales in adults: Which to use?. Am J Emerg Med. 2018; 36(4):707-714. DOI: 10.1016/j.ajem.2018.01.008. View

10.

Djokic M, Cemazar M, Bosnjak M, Dezman R, Badovinac D, Miklavcic D . A Prospective Phase II Study Evaluating Intraoperative Electrochemotherapy of Hepatocellular Carcinoma. Cancers (Basel). 2020; 12(12). PMC: 7765454. DOI: 10.3390/cancers12123778. View

11.

Bill T, Clayman M, Morgan R, Gampper T . Lidocaine metabolism pathophysiology, drug interactions, and surgical implications. Aesthet Surg J. 2009; 24(4):307-11. DOI: 10.1016/j.asj.2004.05.001. View

12.

De Virgilio A, Ralli M, Longo L, Mancini P, Attanasio G, Atturo F . Electrochemotherapy in head and neck cancer: A review of an emerging cancer treatment. Oncol Lett. 2018; 16(3):3415-3423. PMC: 6096208. DOI: 10.3892/ol.2018.9140. View

13.

Sersa G, Ursic K, Cemazar M, Heller R, Bosnjak M, Campana L . Biological factors of the tumour response to electrochemotherapy: Review of the evidence and a research roadmap. Eur J Surg Oncol. 2021; 47(8):1836-1846. DOI: 10.1016/j.ejso.2021.03.229. View

14.

Bertino G, Sersa G, Terlizzi F, Occhini A, Plaschke C, Groselj A . European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer. Eur J Cancer. 2016; 63:41-52. DOI: 10.1016/j.ejca.2016.05.001. View

15.

Plaschke C, Bertino G, McCaul J, Grau J, de Bree R, Sersa G . European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers. Eur J Cancer. 2017; 87:172-181. DOI: 10.1016/j.ejca.2017.10.008. View

16.

Campana L, Edhemovic I, Soden D, Perrone A, Scarpa M, Campanacci L . Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol. 2018; 45(2):92-102. DOI: 10.1016/j.ejso.2018.11.023. View

17.

Lewis S, Pritchard M, Fawcett L, Punjasawadwong Y . Bispectral index for improving intraoperative awareness and early postoperative recovery in adults. Cochrane Database Syst Rev. 2019; 9:CD003843. PMC: 6763215. DOI: 10.1002/14651858.CD003843.pub4. View

18.

Trapani G, Altomare C, Liso G, Sanna E, Biggio G . Propofol in anesthesia. Mechanism of action, structure-activity relationships, and drug delivery. Curr Med Chem. 2000; 7(2):249-71. DOI: 10.2174/0929867003375335. View

19.

Robert C, Soulier A, Sciard D, Dufour G, Alberti C, Boizeau P . Cognitive status of patients judged fit for discharge from the post-anaesthesia care unit after general anaesthesia: a randomized comparison between desflurane and propofol. BMC Anesthesiol. 2021; 21(1):76. PMC: 7948375. DOI: 10.1186/s12871-021-01287-9. View

20.

Strojan P, Groselj A, Sersa G, Plaschke C, Vermorken J, Nuyts S . Electrochemotherapy in Mucosal Cancer of the Head and Neck: A Systematic Review. Cancers (Basel). 2021; 13(6). PMC: 7999968. DOI: 10.3390/cancers13061254. View